Impaired Mast Cell Maturation and Degranulation and Attenuated Allergic Responses inNdrg1-Deficient Mice-Reference-Cited by-同舟云学术

Impaired Mast Cell Maturation and Degranulation and Attenuated Allergic Responses inNdrg1-Deficient Mice

Published:2007-05-18 Issue:11 Volume:178 Page:7042-7053
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Taketomi Yoshitaka,Sunaga Kohei,Tanaka Satoshi,Nakamura Masanori,Arata Satoru,Okuda Tomohiko,Moon Tae-Chul,Chang Hyeun-Wook,Sugimoto Yukihiko,Kokame Koichi,Miyata Toshiyuki,Murakami Makoto,Kudo Ichiro

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference66 articles.

1. Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes

2. Clonal assay of mouse mast cell colonies in methylcellulose culture

3. Mast cells

4. Galli, S. J., M. Tsai, C. S. Lantz. 1999. The regulation of mast cell and basophil development by the kit ligand, SCF, and IL-3. E. Razin, and J. Rivera, eds. Signal Transduction in Mast Cells and Basophils 11-30. Springer-Verlag, New York.

5. Kitamura, Y., E. Morii, T. Jippo. 1999. The c-kit receptor and the mi transcription factor: two important molecules for mast cell development. E. Razin, and J. Rivera, eds. Signal Transduction in Mast Cells and Basophils 31-38. Springer-Verlag, New York.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC6-MYCN-CXCL3 axis mediates allergic inflammation and is necessary for allergic inflammation-promoted cellular interactions;Molecular Immunology;2024-02

2. Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer;Exploration of Targeted Anti-tumor Therapy;2023-10-11

3. Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1;Cancers;2023-05-16

4. NDRG1 is induced by antigen-receptor signaling but dispensable for B and T cell self-tolerance;Communications Biology;2022-11-10

5. Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects;Biomaterials;2022-09